# The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis

> **NCT02398357** · PHASE4 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 96 (estimated)

## Conditions studied

- Portal Vein Thrombosis
- Liver Cirrhosis

## Interventions

- **DRUG:** Nadroparin Calcium and Warfarin

## Key facts

- **NCT ID:** NCT02398357
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02398357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02398357, "The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02398357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*